Greenwich LifeSciences, Inc.
Status: Publicly traded
Direct answer
Greenwich LifeSciences, Inc. is publicly traded on NASDAQ under the ticker GLSI.
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of...
Can you invest in Greenwich LifeSciences, Inc.?
Yes. Greenwich LifeSciences, Inc. is publicly traded on NASDAQ under the ticker GLSI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Greenwich LifeSciences, Inc.
Detailed equity research is provided by MarketSnap.